Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports

por Watson, Sarah, Härmark, Linda
Publicado 2018

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study

por Härmark, Linda, van Puijenbroek, Eugène, van Grootheest, Kees
Publicado 2012

Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre

por Habarugira, Jean Marie Vianney, Härmark, Linda, Figueras, Albert
Publicado 2021

Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana

por Sabblah, George Tsey, Darko, Delese, Härmark, Linda, van Puijenbroek, Eugène
Publicado 2019

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

por Härmark, Linda, Weits, Gerda, Meijer, Rietje, Santoro, Federica, Norén, G. Niklas, van Hunsel, Florence
Publicado 2020

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

por Härmark, Linda, Weits, Gerda, Meijer, Rietje, Santoro, Federica, Norén, G. Niklas, van Hunsel, Florence
Publicado 2020

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes

por Rolfes, Leàn, Härmark, Linda, Kant, Agnes, van Balveren, Leontine, Hilgersom, Wil, van Hunsel, Florence
Publicado 2022

Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis

por van Hoof, Monica, Chinchilla, Katherine, Härmark, Linda, Matos, Cristiano, Inácio, Pedro, van Hunsel, Florence
Publicado 2022

An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini

por Duga, Alemayehu L., Magongo, Sibongile, Nhlabatsi, Siphesihle, Ladwar, Denis O., Härmark, Linda, Rolfes, Leàn
Publicado 2022

Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional St...

por Oosterhuis, Ingrid, Taavola, Henric, Tregunno, Philip M., Mas, Petar, Gama, Sara, Newbould, Victoria, Caster, Ola, Härmark, Linda
Publicado 2018

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre

por Watson, Sarah, Chandler, Rebecca E., Taavola, Henric, Härmark, Linda, Grundmark, Birgitta, Zekarias, Alem, Star, Kristina, van Hunsel, Florence
Publicado 2017

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK

por de Vries, Sieta T., Denig, Petra, Andrić, Adriana, Dimov Di Giusti, Marina, Ptaszynska-Neophytou, Alicia, Härmark, Linda, Mol, Peter G. M.
Publicado 2021

What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects

por van Eekeren, Rike, Rolfes, Leàn, Koster, Andries S., Magro, Lara, Parthasarathi, Gurumurthy, Al Ramimmy, Hussain, Schutte, Tim, Tanaka, Daisuke, van Puijenbroek, Eugène, Härmark, Linda
Publicado 2018

Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries

por Isah, Ambrose O., Opadeyi, Abimbola O., Tumwijukye, Henry, Cobelens, Frank, Smith, Diede, Ndomondo-Sigonda, Margareth, Harmark, Linda, Tanui, Paul, Tiemersma, Edine, Mmbaga, Blandina T., Mahlangu, Gugu, Ayinbuomwan, Stephen A., Soulaymani, Rachida, Pandit, Jayesh M.
Publicado 2023

Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis

por Tiemersma, Everdina W., Ali, Ibrahim, Alemu, Asnakech, Avong, Yohanna Kambai, Duga, Alemayehu, Elagbaje, Cassandra, Isah, Ambrose, Kay, Alexander, Mmbaga, Blandina Theophil, Mmari, Elice, Mwamwitwa, Kissa, Nhlabatsi, Siphesihle, Sintayehu, Kassech, Arefayne, Aida, Teferi, Mekonnen, Cobelens, Frank, Härmark, Linda
Publicado 2021

Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR

por Pierce, Carrie E., de Vries, Sieta T., Bodin-Parssinen, Stephanie, Härmark, Linda, Tregunno, Phil, Lewis, David J., Maskell, Simon, Van Eemeren, Raphael, Ptaszynska-Neophytou, Alicia, Newbould, Victoria, Dasgupta, Nabarun, Wisniewski, Antoni F. Z., Gama, Sara, Mol, Peter G. M.
Publicado 2019

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study

por de Heus, Roel, Mol, Ben Willem, Erwich, Jan-Jaap H M, van Geijn, Herman P, Gyselaers, Wilfried J, Hanssens, Myriam, Härmark, Linda, van Holsbeke, Caroline D, Duvekot, Johannes J, Schobben, Fred F A M, Wolf, Hans, Visser, Gerard H A
Publicado 2009